ONCOLOGIC OUTCOMES ASSOCIATED WITH A SELECTIVE APPROACH TO NEOADJUVANT RADIATION THERAPY IN PATIENTS WITH CT3N0 RECTAL CANCER: RESULTS FROM A RETROSPECTIVE COHORT STUDY.

被引：0
|
作者：
Fournier, F. Rouleau
Dion, G.
Boulanger-Gobeil, C.
Gregoire, R.
Bouchard, A.
Drolet, S.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2017年 / 60卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P534
引用
收藏
页码：E438 / E439
页数：2
相关论文
共 50 条
  • [1] NEOADJUVANT CHEMORADIATION IMPROVES ONCOLOGICAL OUTCOMES IN MIDDLE AND LOWER CT3N0 RECTAL TUMOURS.
    Lavryk, O. A.
    Manilich, E.
    Arshiya, M.
    Champagne, B. J.
    Valente, M. A.
    Kalady, M.
    Shawki, S.
    Gorgun, E.
    Delaney, C. P.
    Steele, S.
    DISEASES OF THE COLON & RECTUM, 2018, 61 (05) : E253 - E253
  • [2] Outcomes of transarterial chemoembolization in neoadjuvant therapy of patients with gastric cancer: A multicenter retrospective cohort study.
    Min, Jiang
    Zhang, Wei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 410 - 410
  • [3] Oncologic feasibility of D1+gastrectomy for patients with cT1N1, cT2N0-1, or cT3N0 gastric cancer
    Kota, Itamoto
    Makoto, Hikage
    Satoshi, Kamiya
    Yutaka, Tanizawa
    Etsuro, Bando
    Masanori, Terashima
    EJSO, 2021, 47 (02): : 456 - 462
  • [4] Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study
    Sorrentino, Luca
    Guaglio, Marcello
    Battaglia, Luigi
    Bonfanti, Giuliano
    Vitellaro, Marco
    Bianchi, Alessandro Cesa
    Milione, Massimo
    Belli, Filiberto
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2019, 34 (12) : 2161 - 2169
  • [5] Clinical staging accuracy and the use of neoadjuvant chemoradiotherapy for cT3N0 rectal cancer: Propensity score matched National Cancer Database analysis
    Burneikis, Dominykas
    Lavryk, Olga
    Gorgun, Emre
    Liska, David
    Valente, Michael
    Sklow, Bradford
    Kalady, Matthew
    Steele, Scott R.
    AMERICAN JOURNAL OF SURGERY, 2021, 221 (03): : 561 - 565
  • [6] Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study
    Luca Sorrentino
    Marcello Guaglio
    Luigi Battaglia
    Giuliano Bonfanti
    Marco Vitellaro
    Alessandro Cesa Bianchi
    Massimo Milione
    Filiberto Belli
    International Journal of Colorectal Disease, 2019, 34 : 2161 - 2169
  • [7] Long-term outcomes and risk profile of cT3N0 breast cancer treated with neoadjuvant chemotherapy and curative surgery
    Shin, Young Seob
    Jeong, Jae Ho
    Chung, Il Yong
    Lee, Jaeha
    Kim, Su Ssan
    Ahn, Seung Do
    Lee, Jong Won
    Son, Byung Ho
    Jung, Jinhong
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2024, 68 (07) : 819 - 827
  • [8] CLINICAL STAGING ACCURACY AND THE ROLE OF NEOADJUVANT CHEMORADIOTHERAPY FOR CT3N0 RECTAL CANCER: PROPENSITY SCORE MATCHED NATIONAL CANCER DATABASE ANALYSIS.
    Burneikis, D.
    Lavryk, O. A.
    Kalady, M.
    Steele, S. R.
    DISEASES OF THE COLON & RECTUM, 2019, 62 (06) : E293 - E294
  • [9] Pathologic and clinical outcomes in cT2N0 esophageal cancer: A cohort study.
    Bhuchar, Gauri
    Altujjar, Mohammad
    Raja, Siva
    Murthy, Sudish C.
    Raymond, Daniel
    Videtic, Gregory M. M.
    McNamara, Michael J.
    Khorana, Alok A.
    Adelstein, David J.
    Sohal, Davendra
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [10] Significant Pathologic Response Following Neoadjuvant Therapy and Curative Resection in Patients With Rectal Cancer: Surgical and Oncological Outcomes From a Retrospective Cohort Study
    Shahabi, Fatemeh
    Ansari, Majid
    Ghobadi, Khadijeh Najafi
    Ghahramani, Abolfazl
    Parandeh, Amiresmaeil
    Saberi-Karimian, Maryam
    Orafaie, Ala
    Abdollahi, Abbas
    CANCER REPORTS, 2024, 7 (11)
12345